As described in the previous section, its anti-inflammatory properties stem from its ability to stabilize an asymmetric conformation of the TNF trimer, and it is under phase 2 investigations for the treatment of RA and plaque psoriasis (McMillan et al., 2021; Vugler et al., 2022). The gene discussed is TNF; the disease is rheumatoid arthritis.